MRI Safety

Overview

MRI is perceived as inherently safe because it does not use ionising radiation. In reality, MRI presents distinct physical hazards from three separate electromagnetic environments, the static magnetic field (always on), the radiofrequency (RF) field, and the rapidly switching gradient magnetic fields, as well as hazards from cryogenic infrastructure, acoustic noise, and the need to bring patients and staff into proximity with an extremely powerful magnet. Comprehensive understanding of these risks, departmental zoning, implant classification, and emergency management is essential for safe practice.

The Static Magnetic Field

Physical Basis

Clinical MRI systems operate at 1.5 T, 3 T, and increasingly 7 T, approximately 30,000 to 140,000 times the Earth's magnetic field of ~50 µT. Superconducting solenoid magnets are maintained at 4.2 K using liquid helium; they are continuously energised and cannot be switched off in normal operation.

Projectile (Missile) Effect

Ferromagnetic objects experience a translational force towards regions of highest field strength, proportional to ferromagnetic content, mass, and the spatial field gradient. The spatial gradient is greatest at the bore entrance. Heavy ferromagnetic objects, oxygen cylinders, IV poles, scissors, tools, can accelerate to lethal velocities. Multiple fatalities have been attributed to failure to prevent ferromagnetic objects entering the scan room. This is the most immediately life-threatening static-field hazard.

Torque

Ferromagnetic implants experience rotational torque as they attempt to align with field lines. Old-style ferromagnetic aneurysm clips are the classic example; torque-induced rotation has caused at least one documented patient death. Modern titanium clips are non-ferromagnetic, but careful implant history remains mandatory.

Induced Currents from Movement Through the Fringe Field

When conductive materials, including body tissues, move through the static fringe field, currents are induced (Faraday's law). This underlies the dizziness, vertigo, metallic taste, and magnetophosphenes reported by personnel and patients moving through the bore at ≥4 T. These effects are transient and reversible at clinical field strengths.

Biological Effects of Static Field

FDA guidelines permit clinical scanning up to 8 T for adults under investigational device exemptions; routine clinical use approved up to 3 T, with 7 T approved under specific conditions.

The Radiofrequency (RF) Field

Mechanism of Tissue Heating

RF pulses applied at the Larmor frequency excite proton spins and deposit energy in tissue, measured as the Specific Absorption Rate (SAR):

$$ \text{SAR} = \frac{\text{Power deposited in tissue (W)}}{\text{Mass of tissue (kg)}} $$

SAR increases with the square of $B_0$, the square of flip angle, and RF pulse repetition rate. The primary biological effect is tissue heating. The most common bioeffect of clinical MR systems is tissue heating caused by RF energy deposition and/or by rapid switching of high-strength gradients.

Regulatory Limits (FDA / IEC)

Patients with impaired thermoregulation (fever, obesity, peripheral vascular disease) are at increased risk.

RF Burns and Induced Currents

Conductive materials (ECG leads, wires, tattoos with metallic pigments, certain transdermal patches) can act as antennas or form conductive loops, concentrating RF energy and causing focal burns at skin-implant interfaces. Precautions include removing metallic jewellery and patches where possible, ensuring cables do not form loops, and padding between the patient and any conductive elements.

The Gradient Magnetic Fields

Physical Basis

Gradient coils switch rapidly during acquisition to provide spatial localisation. Time-varying magnetic fields ($dB/dt$) induce electrical currents in conductive tissue by Faraday's law:

$$ \mathcal{E} = -\frac{d\Phi_B}{dt} = -A \cdot \frac{dB}{dt} $$

where $A$ is the effective cross-sectional area of the conductive loop in tissue. Maximum permissible $dB/dt$ depends on gradient rise time (specified in FDA/IEC regulatory tables).

Biological Effects

MRI Department Safety Zoning

The ACR four-zone model (equivalent frameworks in ARPANSA and MHRA guidance) divides MRI facilities into progressively restricted areas:

The Zone 2-3 boundary is the critical screening checkpoint. The 5 Gauss (0.5 mT) line, the fringe field boundary where programmable and cardiac implanted devices may be affected, must be clearly demarcated.

MR Personnel Levels

Level 2 personnel must maintain credentials through continuous MR safety education and annual competency assessment.

Pregnancy, Lactation, and Breastfeeding

Pregnancy

MRI does not use ionising radiation and carries no radiation-related fetal risk. Current international consensus is that MRI is acceptable during pregnancy when there is a clear clinical indication after careful consideration by the radiologist and relevant clinician. No confirmed teratogenicity, mutagenicity, or adverse fetal outcomes have been demonstrated at standard clinical field strengths (1.5 T, 3 T). Fetal MRI is a recognised investigation in high-risk pregnancies.

• First trimester: Caution is advised, organogenesis is occurring and theoretical (unconfirmed) risks of tissue heating and acoustic trauma are relevant; ultrasound should be used first. If clinical necessity is established, MRI in the first trimester is acceptable.
• Later trimesters: Well established; fetal MRI widely used.
• Gadolinium contrast in pregnancy: Gadolinium-based contrast agents (GBCAs) cross the placenta and recirculate in amniotic fluid. Risk of prolonged fetal exposure and unknown gadolinium deposition in fetal tissue. GBCAs should be avoided in pregnancy unless benefit clearly outweighs uncertain risk.

Lactation and Breastfeeding

Gadolinium is excreted into breast milk in very small quantities (<0.04% of maternal dose). Given poor oral bioavailability, risk to the breastfed infant is considered extremely low. A precautionary 24-hour pause with discarding of expressed milk is traditionally recommended after GBCA administration; however, current evidence supports that continued breastfeeding after standard GBCA doses is safe. Shared decision-making with the mother is appropriate.

Pregnant Staff

Pregnant staff, particularly in the first trimester, should avoid entering Zone 4 during active scanning. Fringe field exposure within Zones 1-2 is not considered hazardous.

Safety Classification of Implants

The Classification System

Note: MR Conditional labelling must address the static magnetic field, the switched gradient magnetic field, and the RF field; additional configuration requirements may apply.

Management of MR Conditional Implants

1. Obtain the implant manufacturer's documentation (device name, model, serial number).
2. Confirm required scanning conditions: maximum static field strength (e.g. 1.5 T only), maximum whole-body SAR, gradient slew rate limits, specific coil types permitted, and maximum spatial field gradient at the bore entrance.
3. Confirm the scanner can operate within those parameters for that specific examination.
4. Note that the spatial field gradient is highest at the bore entrance, table entry speed should be minimised for patients with MR Conditional devices to reduce mechanical force risk.
5. For active implanted devices (pacemakers, ICDs, neurostimulators): liaise with device specialist/cardiology to set device to MR mode before scanning; monitor patient throughout; restore normal programming post-scan.
6. Document all steps and obtain informed consent.

Specific Implant Categories

Emergencies in MRI

Medical Emergencies

When a patient deteriorates or arrests within Zone 4:

• Do not bring ferromagnetic resuscitation equipment into Zone 4. Standard crash carts contain MR Unsafe oxygen cylinders, laryngoscopes, and defibrillators.
• All MRI suites must have MR-compatible emergency equipment (non-ferromagnetic oxygen supply, MR-conditional monitoring, MR-conditional defibrillator if available) within Zone 4 or at the Zone 3/4 boundary.
• Level 2 personnel are the gatekeepers: ensure only screened personnel enter Zone 4; rapidly transfer the patient out of Zone 4 on the MR table or to a non-ferromagnetic trolley to Zone 2/1 where standard resuscitation proceeds.
• Responding anaesthetic and emergency staff must be briefed on MR safety before entry.

Quench

A quench is loss of superconductivity in the main magnet coils, with rapid conversion of stored magnetic energy to heat, vaporising liquid helium (~760-fold volume expansion of helium gas).

• Controlled (deliberate) quench: Initiated via emergency quench button only in life-threatening situations (e.g. a ferromagnetic object pinning a person within the bore). Location of the quench button must be known to all Zone 4 personnel.
• Uncontrolled quench: Spontaneous loss of superconductivity; explosive gas release; risks include oxygen displacement (asphyxiation), pressure build-up preventing door opening, extreme cold surfaces, and physical shock. The magnet sustains a temperature difference of approximately 260 K in a short period; if quenching is too rapid, permanent physical damage to the magnet can occur.
• Response: Evacuate the scan room immediately. Ensure adequate ventilation before re-entry. Deliberate quench should only be initiated in genuine emergencies given the cost, magnet damage, and personnel risks.
• Helium venting: Must be routed externally via the quench pipe. Failure of the vent pipe causes dangerous helium accumulation and oxygen depletion in the scan room.

Fire in the MRI Suite

• The magnet remains active unless quenched; fire response personnel must be pre-briefed that the magnet is always on.
• Standard ferromagnetic fire extinguishers cannot enter Zone 4.
• MR-compatible CO₂ extinguishers must be sited within Zone 4.
• Patient evacuation takes priority; manual quench is considered only if necessary to save a life and the risks of the quench are acceptable.
• Pre-arranged MRI-specific fire evacuation plans and regular drills involving fire services are mandatory.

Safety in Ultrasound

Physical Mechanisms of Bioeffect

Diagnostic ultrasound is non-ionising and is generally safe within standard intensity ranges. Two principal bioeffect mechanisms are recognised:

1. Thermal effects

The Thermal Index (TI) estimates the temperature rise in tissue:

$$ \text{TI} = \frac{W}{W_{\deg}} $$

where $W$ is the acoustic power output and $W_{\deg}$ is the power estimated to raise tissue temperature by 1°C. Subtypes:

• TIS, soft tissue
• TIB, bone at focus
• TIC, cranial bone

Temperature elevation ≥1.5°C in the fetus raises theoretical developmental concern; ≥4°C causes confirmed bioeffects.

2. Mechanical/Cavitation effects

The Mechanical Index (MI) reflects the likelihood of inertial cavitation:

$$ \text{MI} = \frac{P_{neg}}{\sqrt{f}} $$

where $P_{neg}$ is peak negative pressure (MPa) and $f$ is frequency (MHz). MI >1.9 can cause inertial cavitation in gas-containing media. Stable cavitation occurs at lower MI values. Microbubble contrast agents dramatically lower the cavitation threshold; MI should be kept as low as practicable when contrast agents are in use.

ALARA Principle

The ALARA principle applies directly to diagnostic ultrasound:

• Use the lowest output power achieving diagnostic quality.
• Minimise dwell time over sensitive structures.
• Avoid prolonged pulsed/spectral Doppler (highest thermal output mode) over the fetal brain, orbit, and first-trimester embryo.
• Monitor TI and MI displays on the scanner at all times.

Key Safety Thresholds

Specific Safety Considerations

• Obstetric ultrasound: B-mode has the lowest output; colour Doppler is intermediate; pulsed wave (spectral) Doppler is highest. Avoid prolonged spectral Doppler over fetal brain or orbit, particularly in the first trimester.
• Contrast-enhanced ultrasound: Microbubble agents significantly increase cavitation risk; minimise MI.
• Neonatal cranial ultrasound: Thin skull/open fontanelle increases energy transmission; monitor TIB.
• Ophthalmic ultrasound: Minimise power; avoid Doppler over the lens where possible; ISPTA should be kept minimal.
• High-intensity therapeutic ultrasound (HIFU, physiotherapy): Operates outside diagnostic intensity guidelines; not covered by diagnostic safety standards.

Summary: MRI Hazard Comparison

Sources

• ACR Appropriateness Criteria (American College of Radiology)
• ARPANSA (Australian Radiation Protection and Nuclear Safety Agency)
• ICRP publications (International Commission on Radiological Protection)